Evidence map›Paper›PMID 29354801›Full record

ArticleImmunoHorizons2018

IL-27p28 Production by XCR1

Augustus M Kilgore, Seth Welsh, Elizabeth E Cheney, Alisha Chitrakar, Trevor J Blain, Benjamin J Kedl, Chris A Hunter, Nathan D Pennock, Ross M Kedl

Abstract read
In one paragraph

Article in ImmunoHorizons, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. IL-27 promotes Treg cell expression of CD122 and fitness at homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. AnScience immunology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Augustus M KilgoreDepartment of Immunology and Microbiology, School of Medicine, University of Colorado Denver at Anschutz Medical Campus, Denver, CO 80045.
Seth WelshDepartment of Immunology and Microbiology, School of Medicine, University of Colorado Denver at Anschutz Medical Campus, Denver, CO 80045.
Elizabeth E CheneyDepartment of Immunology and Microbiology, School of Medicine, University of Colorado Denver at Anschutz Medical Campus, Denver, CO 80045.
Alisha ChitrakarDepartment of Immunology and Microbiology, School of Medicine, University of Colorado Denver at Anschutz Medical Campus, Denver, CO 80045.
Trevor J BlainDepartment of Immunology and Microbiology, School of Medicine, University of Colorado Denver at Anschutz Medical Campus, Denver, CO 80045.
Benjamin J KedlDepartment of Immunology and Microbiology, School of Medicine, University of Colorado Denver at Anschutz Medical Campus, Denver, CO 80045.
Chris A HunterDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Nathan D PennockDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR 97239.
Ross M KedlDepartment of Immunology and Microbiology, School of Medicine, University of Colorado Denver at Anschutz Medical Campus, Denver, CO 80045.

Funding

TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
Transcriptional regulation of vaccine-elicited and infection-elicited CD8+ T cell responsesR01AI066121 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Ross M Kedl · 2007 to 2026
$7.1M
Molecular and cellular basis of Combined Adjuvant-Elicited Cellular ImmunityR01AI126899 · NIAID · UNIVERSITY OF COLORADO DENVER · PI KEDL, ROSS M · 2016 to 2020
$2.5M
Lymphatic endothelial cell capture and maintenance of antigenR01AI117918 · NIAID · UNIVERSITY OF COLORADO DENVER · PI KEDL, ROSS M · 2015 to 2019
$1.9M
Virtual Memory T Cell Development and Responses In VivoR01AI101205 · NIAID · UNIVERSITY OF COLORADO DENVER · PI KEDL, ROSS M · 2013 to 2017
$1.8M
NIAID NIH HHS R01 AI066121NIAID NIH HHS R01 AI101205NIAID NIH HHS R01 AI117918NIAID NIH HHS R01 AI126899NIAID NIH HHS T32 AI007405
6 · The paper itself

Abstract

It is well accepted that the innate response is a necessary prerequisite to the formation of the adaptive response. This is true for T cell responses against infections or adjuvanted subunit vaccination. However, specific innate parameters with predictive value for the magnitude of an adjuvant-elicited T cell response have yet to be identified. We previously reported how T cell responses induced by subunit vaccination were dependent on the cytokine IL-27. These findings were unexpected, given that T cell responses to an infection typically increase in the absence of IL-27. Using a novel IL-27p28-eGFP reporter mouse, we now show that the degree to which an adjuvant induces IL-27p28 production from dendritic cells and monocytes directly predicts the magnitude of the T cell response elicited. To our knowledge, these data are the first to identify a concrete innate correlate of vaccine-elicited cellular immunity, and they have significant practical and mechanistic implications for subunit vaccine biology.

Identifiers

PMID29354801
PMCPMC5771264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.